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Introduction
Nearly 7000 units of platelet concentrates are needed daily only in the United States (1) . However, platelet concentrates have a limited shelf life of only 5 days and bacterial contaminations pose a serious risk of sepsis to recipients (2) . Attempts to generate platelets in vitro, in order to circumvent these issues, have encountered major problems and only resulted in a limited number of functional platelets (3) . Thus, successful generation of platelets ex vivo remains an unsolved, yet important aim (4) (5) (6) . Essential steps to achieve this goal include uncovering of the molecular mechanisms controlling proplatelet formation and development of a method that allows a robust assessment of platelet formation from megakaryocytes (MKs) in vitro.
One of the most commonly assessed parameters of MK maturation is the percentage of proplatelet-forming MKs, which can vary from 10 to over 60% (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) , depending on the specific quantification technique and the person that scores the MK phenotype. A first attempt to simplify and standardize the quantification of proplatelet formation used an ImageJ macro that distinguishes round from proplatelet-producing cells (22) . This was a major step forward in improving analysis of proplatelet formation, but did not provide all the information needed to understand the processes of platelet generation in more detail.
Here, we developed a novel method, using the open source software CellProfiler, allowing an automated identification, quantification and in-depth characterization of four MK subsets during thrombopoiesis. Our computerized image analysis routine allows identification of undifferentiated, round MKs as well as proplatelet-forming MKs with long, thin extensions, spread MKs with a huge cellular area, pseudopodia-forming MKs with short, thick extensions and terminally differentiated MKs that lack a nucleus. Furthermore, additional information can be extracted, including intensities of biological markers and geometric parameters such as cell area, as a marker for MK spreading and consequently functionality (12, (17) (18) (19) 23) . Based on available sources of stem cells and ethics allowances, we applied our novel image analysis to murine MKs cultured on fibrinogen as this extracellular matrix component of the vascular niche of the bone marrow has been reported to foster proplatelet formation in mice (21) . We are aware that human MKs differ from their murine counterparts given that antibodies blocking the fibrinogen receptor α IIb β 3 did not impede proplatelet development in human cells (12) and MKs from patients with a mutated, constitutive active fibrinogen receptor showed impaired proplatelet formation (24) . Nevertheless, the image analysis technique that we developed for murine MKs has the potential to be applied to MKs from different species and on various matrices, as clearly distinct classes of morphological features are scored and quantified. While the biological relevance of the different categories that we observed is still not clear, we are confident that our method provides an improvement over the coarse differentiation of MKs into immature and proplatelet-forming cells.
Material and methods

MK purification and culture
Mature bone marrow-derived MKs were generated as previously described (20) . Briefly, femora of mice were flushed and cells expressing Ly6G, CD11b, CD16/32 and B220 were depleted using magnetic beads (sheep anti-rat IgG Dynabeads, Invitrogen) and the following antibodies: anti-mouse Ly6G (eBioscience), anti-mouse CD11b (eBioscience), anti-mouse CD16/CD32 (BD Bioscience) and anti-mouse B220 (BD Bioscience), respectively. The remaining cells were incubated in Stempro-34 SFM (Invitrogen) with 2.6% nutrient supplement, 1% glutamine and 1% penicillin-streptomycin-fungizone (PSF) for 2 days in the presence of 20 ng/mL murine stem cell factor (SCF, Peprotech) followed by additional 5 days with 20 ng/mL SCF and 50 ng/mL murine thrombopoietin (TPO, Peprotech). At day 7, mature MKs were enriched using a 3%/1.5%/0% BSA (PAA Laboratories) gradient under gravity for 45 minutes at room temperature.
MK spreading and proplatelet formation assay
Spreading was performed as previously described (20) . Slides were coated overnight with 100 μg/ml fibrinogen at room temperature and blocked for 1 hour with 1% BSA at 37°C. Untreated mature MKs or MKs treated with 10 μM dasatinib or DMSO were allowed to adhere and form proplatelets for 5 hours at 37°C, a time period that has been suggested by several reports (7, 12, 15, (17) (18) (19) (20) . Fixed cells were permeabilized with 0.5% Triton X-100 and labelled with anti-mouse CD41-Alexa Fluor 488 (BioLegend), anti-alpha tubulin-eFluor615 (eBioscience), phalloidin-Alexa Fluor 555 (Molecular Probes) and 5 μg/mL Hoechst 33342 (Molecular Probes). Images were taken with a Nikon A1 plus confocal laser-scanning microscope, using a Plan Apo λ 10x objective (Nikon) NA: 0.45, a Plan Apo λ 20x objective (Nikon) NA: 0.75 and an Apo 40x WI λS DIC N2 objective (Nikon) NA: 1.25. Imaging Software: Nikon NIS-Elements Confocal 4.20.01.
Analysis of proplatelet formation
Images were analysed with the open source software CellProfiler 3.0.0 (25) .25) . "Form Factor" is described as 4Area Perimeter 2 (26), meaning a perfect circle has a value of 1. "Compactness" is the variance of the distance of the cells' pixels from the centroid divided by the area (26). A perfect circle, having no variances in pixel-centroid distances, has therefore a Compactness value of 0. Manual counting was conducted by searching for MKs with long, thin extensions.
Statistical analysis
Calculations were performed using GraphPad Prism 6.01 software. Data were analysed using Student's t-test or two-way ANOVA and Sidak's multiple comparison test. Statistical significances are depicted as: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Bars are mean; error bars represent standard deviation (SD).
Results and discussion
Mature bone marrow-derived MKs were allowed to spread on fibrinogena method used to foster proplatelet formation, fixed and stained for CD41 and DNA followed by confocal imaging. While we were able to detect cells that showed typical proplateletforming shapes as known from literature ( Figure 1A ), other cells could not be categorized clearly ( Figure 1B -D). This may explain the variation in the percentage of proplatelet-forming MKs found in different studies (7-21) (Supplemental Table 1 ). There have been previous attempts to classify maturing MKs into different stages, and proplatelet-forming MKs have been dissected into two developmental stages (7, (27) (28) (29) . Our morphological evaluation revealed five major subtypes, which can be described as follows:
(1) Proplatelet-forming MKs: cells with tubulin-positive extensions ≤ 10 μm thin and a length exceeding the cell body axis twofold or MKs with high protrusion complexity ( Figure 1A ). (2) Spread MKs: large MKs that contain actin nodules ( Figure 1B ) as previously reported (18, 30) . Due to their large, flat cell bodies, they clearly differ from normal, round undifferentiated MKs, but cannot be considered classical proplatelet-forming MKs either. (3) Pseudopodia-forming MKs: cells with tubulin positive cellular extensions that are too thick and/or short to be classified proplatelet-forming MKs ( Figure 1C ). (4) Terminally differentiated MKs: anucleated MKs ( Figure 1D ) that could reflect the in vivo situation of nucleus extrusion and degradation at the final phase of thrombopoiesis (31). (5) Undifferentiated MKs: Small round, nucleated cells ( Figure 1E ).
In order to objectively classify these distinct subsets, we measured morphological parameters of MKs that were representative for the different subclasses using the free image analyses software package CellProfiler. Thereby, we tried to describe the five categories mathematically in a most accurate, yet simple way. The resulting differentiation parameters such as form factor, area or compactness were used to establish an automated analysis routine (available at: http://cellprofiler.org/examples/published_pipelines). First, nucleated and anucleated MKs were identified from fluorescence images based on their CD41 and Hoechst 33342 staining ( Figure 2Ai ) and smoothed to prevent perimeter to area ratio artefacts (Figure 2Aii ). Cells were then classified into five different subtypes and additional quantitative information like marker intensities, cell area or the number of adjacent cells can be extracted (Figure 2Aiii ).
Terminally differentiated MKs that lack a nucleus ( Figure 1D ) were identified in the first step of CellProfiler analysis and did not need further classification ( Figure 2 ). The second step classified nucleated MKs following a series of morphological and geometrical criteria, depicted in Figure 2B . Threshold values were selected empirically based on CellProfiler analysis of manually classified cells (meeting the above-mentioned criteria), using representative images.
The second subtype to be identified are morphologically complex proplatelet-forming MKs ( Figure 1A) , described by a Form Factor ≤ 0.19. Cells with a simpler morphology were further classified depending on their size. Cells with an area > 6000 μm 2 were considered spread MKs ( Figure 1B ). Applying the selection criteria for spread MKs as a second step ensures that MKs with long, complex proplatelets that may exceed 6000 μm 2 cell area are correctly classified as proplatelet-forming MKs. Finally, pseudopodia-forming MKs ( Figure 1C ) were distinguished from round, undifferentiated MKs ( Figure 1E ) using a Compactness threshold of 1.25. This pseudopodia-forming cells might represent early stages of proplatelet formation; a hypothesis, which may be tested in future studies involving time-lapse microscopy of MK maturation.
To validate our pipeline, we compared manually and automatically analysed images ( Figure 3A) . The results show a significant inter-observer variability. This was apparently due to interpretation disparity between proplatelet-forming MKs and what we now define as pseudopodia-forming MKs having thicker extensions. The comparison between manual and computer-based evaluation of proplatelet-forming cells indicated that some individuals tend to score MKs with pseudopodia as proplatelet-forming. These inter-observer differences might also explain at least in part the huge variation of the reported percentages of proplatelet-forming MKs in literature, which might also depend on matrix type, cell source and MK incubation time (Supplemental Table 1 ). The computer-based method was clearly more stringent and could furthermore analyse substantially more cells without additional effort, leading to a more accurate result ( Figure 3A) . To test whether the complex morphology of MKs impedes CellProfiler's automated cell identification, we also compared the automated cell recognition and separation with a manual segregation of cells by drawing a background-coloured line between overlapping or touching cells ( Figure 3B ). In total, 3788 automatically separated and 3805 manually separated cells were identified and analysed, without observing significant differences in percentages ( Figure 3C , 3D) or cell areas ( Figure 3E ) of all differentiated MKs combined. Noteworthy, the mean percentages of differentiated, i.e. usually defined as proplatelet-forming MKs as described in literature (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) is in line with the sum of all differentiated MK-categories of our analysis (22.87 ± 16.03% vs 32.86 ± 2.73%, respectively; Figure 3C ). However, a more detailed discrimination, using our computer-based analysis tool, revealed that only part of differentiated MKs scored as proplatelet-forming, with a much higher percentage of cells exhibiting pseudopodia ( Figure 3D ).
This showed that our algorithm accurately identifies the complex morphology of MKs and is able to segregate overlapping or touching cells with its automated separation routine.
Using this automated and unbiased analysis, we observed 3.9% proplatelet-forming, 6.1% spreading, 17.8% pseudopodiaforming and 5.6% terminally differentiated MKs under our culture conditions ( Figure 3D ). Pseudopodia-forming MKs with an average of 3054 μm 2 had twofold less cell area than MKs forming actual proplatelets ( Figure 3F ), demonstrating that although they resemble proplatelet-forming MKs at first glance, they significantly differ in their cell area due to their lack of proper proplatelets. These may represent cells that are just initiating proplatelet formation. Seeding cells at varying densities did not result in significant differences in the total numbers of differentiated cells. However, a slight reduction of pseudopodia-forming MKs was observed at lower cell densities. (Supplemental Figure 1) .
To further evaluate the applicability of our automated MK classification for pharmacological studies we treated cells with dasatinib, a drug that is known to influence MK maturation and to cause mild thrombocytopenia in patients. It is a potent, ATPcompetitive inhibitor of several tyrosine kinases, which diminishes proplatelet formation and spreading in vitro (17) . Applying our automated workflow, we observed almost exactly the same significant overall decrease in MKs undergoing thrombopoiesis as previously reported: The percentage of differentiating MKs decreased in presence of dasatinib from 32.3 to 13.9% ( Figure 4A ), whereas spread MKs and pseudopodia-forming MKs were affected the most (8.4 to 0.6% and 17.0 to 8.7%, respectively). Proplatelet-forming MKs also decreased from 1.7 to 0.2% ( Figure 4B ) and could only be detected in one sample. Furthermore, dasatinib also decreased the mean cell area from 2620 μm 2 to 1148 μm 2 ( Figure 4C) , with proplatelet-forming MKs being reduced by 71% from 8170 μm 2 to 2375 μm 2 ( Figure 4D ). Representative images of MKs treated with dasatinib are shown in Figure 4E . Hence the reduction of MKs undergoing thrombopoiesis was mainly due to diminished proplateletforming and spreading MKs and a reduction of pseudopodiaforming MKs. Furthermore, cell area of proplatelet-forming MKs was decreased upon dasatinib treatment, also confirming a reduction of proplatelets. These observations on the inhibitory effect of dasatinib on thrombopoiesis provide a deeper insight into the cause of mild thrombocytopenia that is noticed in patients treated with dasatinib for imatinib-resistant chronic myelogenous leukaemia (17) . In order to test our image analysis routine and the effect of dasatinib treatment on a different matrix than fibrinogen, we furthermore performed experiments with MKs seeded on fibronectin. There we found a similar reduction in proplatelet and pseudopodia formation, however, with higher variability and a higher fraction of anucleated MKs (Supplemental Figure 2) .
Conclusion
We provide a novel, automated, reproducible and sensitive method to evaluate differentiation and proplatelet formation of MKs based on their morphology. Besides introducing new MK subtypes during thrombopoiesis, our method provides solid comparability with previous reports, as the results of our automated MK cell classification are in line with published values of manually counted cells, while being more time-effective and unbiased. Variations between studies may partially derive from non-standardized definition of proplatelet-forming MKs and from individual differences in morphology assessments. Our novel workflow is sensitive enough to monitor and quantify not only reported changes in proplatelet formation but also spreading of MKs. The five categories of MK morphology that we distinguish with our approach might not directly reflect biological stages of the differentiation and maturation process. Furthermore, the transition from one category to another might be gradual. Future studies will be necessary to assign the expression of relevant marker or driver genes of MK maturation to the various categories that we propose here. Moreover, machine-learning methods of image analysis in combination with staining of relevant biomarkers might be applied for a more fine-tuned classification. This may result in even more categories and link the morphological categorization to a defined biological staging of MK maturation and proplatelet formation.
Although we used murine MKs derived from bone marrow stem cells, this pipeline is likely to be also applicable for MKs derived from other sources. In our standardized routine, we used fibrinogen, which is localized to vascular sinusoids (21) and represents a sound inducer of murine proplatelet formation in vitro (12, 32) . However, other methods to induce proplatelets would be equally possible and compatible with our CellProfiler's analysis, as long as fluorescent images of cell bodies and nuclei are analysed. The exact biological function of pseudopodia-forming MKs and spread MKs remains to be elucidated. However, we were able to observe a moderate reduction of pseudopodia-forming cells and a strong reduction of spread MKs after dasatinib treatment, indicating reduced MK function, leading to thrombocytopenia (17) .
Taken together, we present a novel method for automated MK classification and quantification of proplatelet formation using a new pipeline for the free CellProfiler software. The advantage of our approach over current analysis tools is that it reduces inter-institutional differences via introduction of an unbiased, investigator-independent and time-saving analysis tool, which can score a high number of cells in a robust and objective manner, thereby also improving statistical analyses. This opens the possibility for high-throughput screening of substances or treatments that influence MK maturation and development of proplatelets.
Yet, our method has the limitation that it relies on fluorescence staining of MKs and is thus not applicable to transmission light microscopy images of MKs. Furthermore, the analysis parameters that we worked out for our system (as defined in Figure 2 ) might have to be adjusted for the analysis of MKs from other sources or grown on other extracellular matrices. It is evident that computer-based image analysis cannot rule out miss-classification or erroneous cell segmentation completely; however, its automated, unbiased nature and the potential for classifying high numbers of cells outperforms manual, individual evaluation.
Overall, we are convinced that an improved quantification of platelet formation will provide a valuable basis for new insights in MK and platelet research, thereby fostering the development of ex vivo generation of platelets. Ultimately, this could reduce the demand of blood donors for platelet concentrates and would further offer the possibility for autologous platelet transfusion. As a consequence, recipient patients would benefit from diminished risks of infections or autoimmune diseases.
